RT @liver_OMICs: Exciting work from two of our group @ElizabethShirin and @MegIllingworth1 on a machine learning approach to drug predictio…
RT @ElizabethShirin: super happy that our translational work on AI in liver cancer has been published https://t.co/syqBSbAMFC https://t.co…
RT @liver_OMICs: Exciting work from two of our group @ElizabethShirin and @MegIllingworth1 on a machine learning approach to drug predictio…
Exciting work from two of our group @ElizabethShirin and @MegIllingworth1 on a machine learning approach to drug predictions for liver cancer #MachineLearning #Cholangiocarcinoma https://t.co/4Jl4P9RQ6V
RT @ElizabethShirin: super happy that our translational work on AI in liver cancer has been published https://t.co/syqBSbAMFC https://t.co…
RT @ElizabethShirin: super happy that our translational work on AI in liver cancer has been published https://t.co/syqBSbAMFC https://t.co…
RT @ElizabethShirin: super happy that our translational work on AI in liver cancer has been published https://t.co/syqBSbAMFC https://t.co…
super happy that our translational work on AI in liver cancer has been published https://t.co/syqBSbAMFC https://t.co/S8b8UQt41t
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets https://t.co/ditEJOpORb https://t.co/FdsBOUykhi
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets https://t.co/4MCGDIEHfM https://t.co/LgLNcMaHUQ
Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets https://t.co/sxRHy2Kr6o
Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets https://t.co/TCavYNuxHX https://t.co/drz3NV3YIz
Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets #CancerRes #MassSpec https://t.co/KmwtEPVGy8
Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets https://t.co/QrmWFW9tWW
New article: Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets https://t.co/DsbNmFtSMn #livercancer #oncology https://t.co/NJOvc1y8KH